CNC$44.88
$44.36
Chart
Performance
Key Stats
AI CNC Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyCentene Corporation (CNC) shows a mixed investment profile. Fundamentally, it demonstrates solid revenue and earnings growth, with a reasonable valuation, but the company carries significant debt. The technicals suggest a strong downtrend, indicating potential short-term headwinds. Thematic exposure to healthcare is positive, but the specific segment's growth drivers need careful monitoring.
Thematic
Centene operates within the healthcare sector, specifically focused on government-sponsored healthcare programs. While the overall healthcare demand is a long-term positive, specific regulatory changes and competition within the managed care market present moderate thematic risks and opportunities.
Fundamental
Centene demonstrates robust revenue growth and consistent profitability, with positive earnings surprises in recent quarters. Its balance sheet shows substantial assets and equity, though debt levels are significant. Valuation metrics like P/E are relatively low, suggesting potential undervaluation.
Technical
The stock has experienced a significant decline over the past year and exhibits bearish technical indicators across multiple timeframes, with most moving averages signaling 'Sell'. RSI is in oversold territory, suggesting a potential for a bounce, but overall momentum is weak.
| Factor | Score |
|---|---|
| Healthcare Demand (Managed Care) | 70 |
| Regulatory Environment (Government Programs) | 40 |
| Competition in Managed Care | 50 |
| Expansion into New Services | 65 |
| Operational Efficiency & Integration | 50 |
| Factor | Score |
|---|---|
| Valuation | 95 |
| Profitability | 90 |
| Growth | 80 |
| Balance Sheet Health | 40 |
| Cash Flow | 75 |
| Dividend Yield | 0 |
| Factor | Score |
|---|---|
| Trend Analysis | 10 |
| Momentum | 30 |
| Volume Confirmation | 60 |
| Support & Resistance | 50 |
| Short-term Oscillators | 40 |
AI Investing Checklist
Powered by LiveAIBullish Points (5)
Consistent Earnings Surprises
The company has a history of beating earnings per share (EPS) estimates, with 7 out of the last 8 quarters showing positive surprises, indicating strong operational execution and forecasting accuracy.
Undervalued Relative to Earnings
The Price-to-Earnings (P/E) ratio of 3.95 (TTM) is significantly lower than the industry average, suggesting the stock may be undervalued given its current earnings.
Bearish Points (7)
Significant Long-Term Underperformance
The stock has experienced substantial declines over multiple periods, with a -59.39% performance over the last 6 months and -63.39% over the last year, indicating significant headwinds and investor concerns.
High Price-to-Sales Ratio
The Price-to-Sales (P/S) ratio of 0.1 (TTM) is low, which, combined with declining stock price, might indicate market skepticism about future revenue generation or profitability, despite appearing cheap on this metric alone.
Calendar
July 2025
25
Next Earnings Date
H: $1.54
A: $0.23
L: $-1.02
H: 45.42B
A: 44.20B
L: 43.24B
Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Seasonals
Price Target
49.91 USD
The 39 analysts offering 1 year price forecasts for CNC have a max estimate of 91.50 and a min estimate of 30.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 98
Direct competitor focused on government-sponsored healthcare programs (Medicaid, Medicare, ACA Marketplace), very similar business model to Centene.
Weight: 95
The largest managed care organization (MCO) and direct competitor across most healthcare segments, including government programs (Optum and UnitedHealthcare segments).
Weight: 90
Formerly Anthem, a major MCO and direct competitor, offering a wide range of health plans including commercial, Medicaid, and Medicare.
Weight: 88
A significant MCO with a strong focus on Medicare Advantage plans and other government-sponsored programs, leading to direct competition with Centene.